4//SEC Filing
Shiff Susan Ph.D. 4
Accession 0001209191-20-039488
CIK 0001346830other
Filed
Jun 29, 8:00 PM ET
Accepted
Jun 30, 4:51 PM ET
Size
5.6 KB
Accession
0001209191-20-039488
Insider Transaction Report
Form 4
Shiff Susan Ph.D.
Director
Transactions
- Award
Stock Option (Right to Buy)
2020-06-26+38,000→ 38,000 totalExercise: $17.03Exp: 2030-06-26→ Common Stock (38,000 underlying)
Footnotes (1)
- [F1]The option shall vest and become exercisable in twelve (12) equal quarterly installments beginning on September 26, 2020 such that the option will be fully vested and exercisable on June 26, 2023, subject to the Reporting Person's continued service to the Issuer on each such date.
Documents
Issuer
Cara Therapeutics, Inc.
CIK 0001346830
Entity typeother
Related Parties
1- filerCIK 0001811463
Filing Metadata
- Form type
- 4
- Filed
- Jun 29, 8:00 PM ET
- Accepted
- Jun 30, 4:51 PM ET
- Size
- 5.6 KB